Study of Difluprednate in the Treatment of Uveitis

Sirion Therapeutics, Inc.

Overview

The purpose of this study is to determine the safety and efficacy of difluprednate compared with prednisolone acetate in the treatment of endogenous anterior uveitis.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Masking

DOUBLE

Conditions

Uveitis

Interventions

DifluprednateDRUG

Prednisolone AcetateDRUG

Eligibility

Sex: ALLMin age: 2 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Diagnosis of endogenous anterior uveitis in at least 1 eye Exclusion Criteria: * Presence of intermediate uveitis, posterior uveitis or panuveitis * Corneal abrasion * Any confirmed or suspected active viral, bacterial, or fungal keratoconjunctival disease * Allergy to similar drugs, such as other corticosteroids

Locations (1)

John-Kenyon American Eye Institute

New Albany, Indiana, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.